A 52-year-old man with chest pain and tachycardia has ECG evidence of an acute MI. The following is/are true:
A. Thrombolytic therapy should be considered immediately since the benefit is greater the earlier it is given
B. Of the drugs available, recombinant tPA produces better results than SK or APSAC although it is more expensive
C. Thrombolytic therapy requires catheterization for intracoronary administration
D. Addition of heparin and antiplatelet drugs produces no incremental benefit
Answer:A
A 52-year-old man with chest pain and tachycardia has ECG evidence of an acute MI. The following is/are true:
A. Thrombolytic therapy should be considered immediately since the benefit is greater the earlier it is given B. Of the drugs available, recombinant tPA produces better results than SK or APSAC although it is more expensive C. Thrombolytic therapy requires catheterization for intracoronary administration D. Addition of heparin and antiplatelet drugs produces no incremental benefit